Evidence map›Paper›PMID 36139728›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Metabolite Profiling Analysis and the Correlation with Biological Activity of Betalain-Rich

Aneta Spórna-Kucab, Anna Tekieli, Agnieszka Grzegorczyk, Łukasz Świątek, Barbara Rajtar, Krystyna Skalicka-Woźniak, Karolina Starzak, Boris Nemzer, Zbigniew Pietrzkowski, Sławomir Wybraniec

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Biotechnologia · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Aneta Spórna-KucabDepartment of Chemical Technology and Environmental Analysis, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland.ORCID 0000-0002-6653-3702
Anna TekieliDepartment of Chemical Technology and Environmental Analysis, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland.ORCID 0000-0003-1147-9136
Agnieszka GrzegorczykChair and Department of Pharmaceutical Microbiology, Medical University of Lublin, 1 Chodźki Str, 20-093 Lublin, Poland.ORCID 0000-0002-2812-5046
Łukasz ŚwiątekDepartment of Virology with SARS Laboratory, Medical University of Lublin, 1 Chodźki Str, 20-093 Lublin, Poland.ORCID 0000-0003-1626-680X
Barbara RajtarDepartment of Virology with SARS Laboratory, Medical University of Lublin, 1 Chodźki Str, 20-093 Lublin, Poland.
Krystyna Skalicka-WoźniakDepartment of Natural Products Chemistry, Medical University of Lublin, 1 Chodźki Str, 20-093 Lublin, Poland.ORCID 0000-0002-9313-5929
Karolina StarzakDepartment of Chemical Technology and Environmental Analysis, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland.ORCID 0000-0002-0343-5363
Boris NemzerResearch and Analytical Center, VDF FutureCeuticals, Inc., 2692 N. State Rt. 1-17, Momence, IL 60954, USA.
Zbigniew PietrzkowskiDiscovery Research Lab, VDF FutureCeuticals, Inc., 23 Peters Canyon Rd., Irvine, CA 92606, USA.
Sławomir WybraniecDepartment of Chemical Technology and Environmental Analysis, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland.ORCID 0000-0002-1263-4188
Cracow University of Technology · PLMedical University of Lublin · PLUniversity of Illinois Urbana-Champaign · USVan Drunen Farms (United States) · US

Funding

FutureCeuticals, Inc. Company; 2692 IL-1, Momence, IL 60954, USA private financial support
6 · The paper itself

Abstract

The aim of the study was to evaluate the possible correlation between the bioactivity and the phytochemical profile of four betalain-rich extracts from Portulaca grandiflora Hook. The HPLC-DAD-ESI-MS analysis indicated the presence of 19 betaxanthins and two betacyanins. The highest concentrations of betaxanthins (982 mg/100 g DE) and betacyanins (650 mg/100 g DE) were noticed in orange and purple flowers extracts, respectively. The HPLC-DAD-ESI-HRMS/MS analyses revealed the presence of a total of 71 compounds. Fifteen new betaxanthins and fifty other metabolites were identified for the first time. The antioxidant activity of the studied flower extracts increased in the sequence of yellow < orange < purple < red (0.066−0.176 mM TE/g DE). Betalains showed less effect on the antioxidant activity of extracts than other metabolites did. Extracts from yellow and orange flowers were more active against Gram-positive bacteria (MIC = 4−16 mg/L), whereas extracts from red and purple flowers were slightly more active against Gram-negative bacteria (MIC = 16−32 mg/L). All the extracts showed the same activity against yeasts (MIC = 32 mg/L). Betaxanthins were active against Gram-positive bacteria, whereas betacyanins were active against Gram-negative bacteria. Remaining metabolites also exhibited antimicrobial activities. The cytotoxicity assessment showed that the P. grandiflora extracts were non-toxic to normal VERO cells. No significant antiviral activity towards Human Herpesvirus type 1 was observed (62 µg/mL). Among the tested varieties, the purple one showed anticancer selectivity towards colon carcinoma cells (RKO).

Indexed as

antimicrobialantioxidantantiviralbetalainscytotoxicityPortulaca grandiflora Hook.

Identifiers

PMID36139728
PMCPMC9495615
OpenAlexW4293106366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.